摘要
目的:探讨慢性淋巴细胞白血病(CLL)检测t(11;14)、CD5和CD23的诊断价值。方法:采用流式细胞术(FCM)和常规细胞遗传学(CC)对45例初诊为CLL的患者进行免疫学和细胞遗传学检测,并采用间期荧光原位杂交(FISH)技术进行t(11;14)的研究。结果:45例初诊CLL中,CC均未见t(11;14)异常,FCM示5例CD5+CD23-,40例CD5+CD23+。5例CD5+CD23-患者中,4例经I-FISH检测出具有t(11;14)异常。40例CD5+CD23+患者中,I-FISH检测无一例有t(11;14)异常。结论:t(11;14)、CD5和CD23在CLL诊断中具有重要意义,CLL免疫表型多为CD5+CD23+,且无t(11;14)异常。少数套细胞淋巴瘤(MCL)误诊为CLL,MCL多有t(11;14)异常,免疫表型为CD5+CD23-。
Objective:To investigate the role of detecting t(11;14),CD5 and CD23 in diagnosis of chronic lymphocytic leukemia(CLL).Method:Flow cytometry(FCM) and conventional cytogenetics (CC) were performed in 45 patients who were firstly diagnosed as CLL,then interval fluorescence in situ hybridization(I-FISH) was performed in all patients.Result:All patients were negative with t(11;14) in CC.FCM results showed that 5 patients were CD5+CD23-and 40 patients were CD5+CD23+.Four patients with CD5+CD23-were positive with t(11;14) by I-FISH,but no patients with CD5+CD23+ were positive with t(11;14) by I-FISH.Conclusion:Examination of t(11;14),CD5 and CD23 plays an important role in diagnosing CLL.CLL shows features of t(11;14) negative and CD5+ CD23+.A few of mantle cell lymphoma(MCL) cases are misdiagnosed as CLL. MCL is identified as t(11;14) and CD5+ CD23-.
出处
《临床血液学杂志》
CAS
2011年第2期129-132,共4页
Journal of Clinical Hematology
基金
江苏省自然基金项目(No:BK2007249)
江苏省社会发展计划项目(No:BS2007075)
江苏省盐城市医学科技发展计划项目(No:YK2008100)